Diabetic Control Measures for Patients with Severe Renal Impairment and Acute Illness

Immediate Insulin Management

• The American College of Physicians recommends reducing total daily insulin dose by 50% immediately in patients with chronic kidney disease stage 4 and acute illness, due to decreased renal insulin clearance and impaired renal gluconeogenesis 1
• Patients with significant creatinine elevations have a 5-fold increase in severe hypoglycemia risk when on insulin, according to the American Journal of Kidney Diseases 2, 3
• The American Diabetes Association advises against discontinuing insulin therapy entirely, even during acute illness with fever, as insulin needs often increase during illness despite decreased food intake 4

Linagliptin Adjustment

• The American College of Cardiology recommends discontinuing linagliptin temporarily during acute illness with vomiting, diarrhea, or significant fluid losses to prevent hypoglycemia 5
• The combination of insulin plus DPP-4 inhibitor significantly increases hypoglycemia risk in advanced chronic kidney disease, according to the American Journal of Kidney Diseases 1

Dapagliflozin Management

• The American Geriatrics Society recommends discontinuing dapagliflozin permanently in patients with creatinine 2.8 mg/dL (estimated eGFR <30 mL/min/1.73 m²), as it is contraindicated and ineffective for glycemic control 2, 6

Glycemic Targets

• The American College of Physicians recommends a target HbA1c of 7.5-8.0% in patients with advanced chronic kidney disease and acute illness, with individualized targets ranging from <6.5% to <8.0% 7, 3
• The American Diabetes Association advises targeting HbA1c above 7.0% to minimize hypoglycemia risk in patients with advanced chronic kidney disease (stage 4), co-morbidities, and age >70 years 3

Monitoring Strategy

• The American College of Cardiology recommends increasing home blood glucose monitoring to 4 times daily during acute illness and for 2 weeks after insulin dose adjustment, to detect hypoglycemia patterns in advanced chronic kidney disease 1
• The American Geriatrics Society advises monitoring serum creatinine and electrolytes weekly during acute illness and monthly thereafter 2

Insulin Titration Algorithm Post-Acute Illness

• The American Diabetes Association recommends continuing reduced insulin dose and monitoring fasting and pre-dinner glucose daily for 1-2 weeks after fever resolves and oral intake normalizes, before adjusting the dose further 1

Critical Safety Considerations

• The American College of Physicians recommends educating patients and families on hypoglycemia recognition and treatment, as hypoglycemia awareness may be impaired in advanced chronic kidney disease 1
• The American Geriatrics Society advises avoiding first-generation sulfonylureas entirely in elderly patients with renal impairment due to prolonged half-life and severe hypoglycemia risk 8, 2
• The American College of Cardiology recommends avoiding metformin in patients with creatinine 2.8 mg/dL (>1.4 mg/dL in women) due to lactic acidosis risk 8, 6